Legal Archives - Page 2 of 5 - Life Sciences Times

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

THIS WEEK'S STORIES

Niagen Bioscience Reports Results from First Randomized Controlled Trial of Niagen Supplementation in Individuals with Long COVID

November 13, 2025

Odyssey Therapeutics Names Dennis Dean, Ph.D., Executive Vice President and Head of Non-Clinical Development

November 11, 2025

Kaneka Expands Global Availability of i-ED Coil with European Launch

November 10, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals

Enveric Biosciences Retains Fish & Richardson to Defend U.S. Patent Linked to Bretisilocin Following AbbVie’s $1.2 Billion Acquisition

Los Angeles Jury Awards Nearly $1 Billion Against Johnson & Johnson in Mesothelioma Talc Case

Boston Jury Awards $83 Million in Asbestos Verdict Against American Art Clay Company

NeoGenomics Scores Court Victory as Judge Invalidates Natera Patents, Clears Path for RaDaR ST Assay

Most Read

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Cognision Partners with Kynexis to Use COGNISION System in Phase 2 Trial of KYN-5356 for Schizophrenia

Sensus Healthcare Expands Role of President Michael Sardano to Chief Commercial Officer

Dexcom Reveals Global Diabetes Advocates for World Diabetes Day

EDITOR PICKS

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

THIS WEEK'S STORIES

Niagen Bioscience Reports Results from First Randomized Controlled Trial of Niagen Supplementation in Individuals with Long COVID

Odyssey Therapeutics Names Dennis Dean, Ph.D., Executive Vice President and Head of Non-Clinical Development

Kaneka Expands Global Availability of i-ED Coil with European Launch

POPULAR CATEGORY

ABOUT US

FOLLOW US